Sunday, January 15, 2012

Call for Speakers & Posters: EBF 3rd Focus Meeting

EBF - European Bioanalysis Forum 3rd Focus Meeting “Hatching”
Emerging Technologies Approaching the Regulated Bioanalysis Laboratory
12-13 June 2012 Sheraton, Brussels, Belgium

Almost 200 scientists met in Brussels in 2011 for the 2nd EBF Focus meeting on peptide and protein analysis with MS technologies ("Large meets Small"). This year again the EBF is pleased to announce that sponsorship for its 3rd Focus meeting is open. In 2012, we will focus our attention on Emerging Technologies approaching the Regulated Bioanalysis Laboratory.
In the last 5 years, we have seen an explosion of new technologies and platforms maturing and becoming available to the bioanalytical scientist. Parallel to this, regulatory requirements for bioanalysis are developing at a similar pace.
With scientific developments and regulatory expectations not always in concert, our 3rd Focus meeting aims to connect on the potential of a broad array of new technologies. We will provide a scientific hub for the development of strategies which may enable the application of these emerging technologies to their full potential in regulated bioanalysis.

Plenary session
  • What’s new in 'Sample Enrichment Technology'
    • Miniaturization and/or automation of sample preparation techniques?
    • How can antibody technologies help with sample enrichment for quantification?
  • Recent developments in tissue analysis
    • Tissue analysis (including micro sampling) and PK/PD
    • Is Tissue imaging approaching quantitative bioanalysis expectations?
  • Global Bioanalysis Consortium (GBC) feedback session
Breakout sessions
  • Small molecules: miniaturization and diversification in LC-MS interfacing
    • Miniaturization of LC using ‘conventional’ MS ionization techniques
    • Alternative MS-interfaces for quantitative bioanalysis
  • Macro molecules: Emerging platforms in support of LBA
    • Recent new technologies Methodologies
    • Recent new technologies Experiences with applications and validations
Each session intends to have 4 speakers (1 keynote of 30 minutes and 3 contributions of 20 minutes). For details on the goals and objectives of each session, please visit the conference website at

Potential speakers, please submit the title and abstract of your presentation (before 31 March 2012) to conference address:, attaching a filled out oral presentation submission form available on the conference website. Acceptance of your presentation will be communicated before 15 April 2011.

There will be room for approx. 30 posters. Please submit the title and abstract of your poster (before 15 May 2012) to conference address:, attaching a filled out poster presentation submission form available on the conference website. Supported Poster format is Portrait (size A0).

Benno Ingelse (MSD), Arjen Companjen (Crucell), John Smeraglia (HLS), Hans Mulder (Astellas), Margarete Brudny-Kloeppel (Bayer Healthcare), Peter van Amsterdam (Abbott Healthcare Products), Neil Henderson (AstraZeneca) & Philip Timmerman (Janssen Research & Development)

Christina Smith, Bavalan Bioconference

The conference is organised as a non-profit event by European Bioanalysis Forum VZW 

No comments:

Post a Comment